Shoichi Hishinuma
Shoichi Hishinuma publishes mostly in Oncology, Surgery and Pulmonary and Respiratory Medicine, on topics such as Pancreatic and Hepatic Oncology Research, Cholangiocarcinoma and Gallbladder Cancer Studies and Gastric Cancer Management and Outcomes.
- World rank
- #4,549,924 of 7,710,434 ranked researchers
- Rank in Japan
- #133,232 of 383,136
- Works
- 83
- Citations
- 2.6k
- Citations per work
- 31.6
What does Shoichi Hishinuma research?
Shoichi Hishinuma's work is mostly in Medicine (74%), Biochemistry, Genetics and Molecular Biology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences6274.4%
- Medicine6274.4%
- Everything else1821.6%
- Life Sciences34.0%
- 1Oncology26% of their works
- 2Surgery20% of their works
- 3Pulmonary and Respiratory Medicine19% of their works
- 4Epidemiology6% of their works
- 5Hepatology4% of their works
- 6Cancer Research4% of their works
Research topics
- Pancreatic and Hepatic Oncology Research
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Gastric Cancer Management and Outcomes
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Genomics and Diagnostics
- Neuroendocrine Tumor Research Advances
- Gastrointestinal Tumor Research and Treatment
- Renal cell carcinoma treatment
Which keywords describe Shoichi Hishinuma's research?
The keywords of their largest research topics: Chemotherapy, Immunotherapy, Pancreatic Cancer, Surgical Complications, Prognostic Factors, Surgical Management, Clinical Practice Guidelines and Molecular Characterization.
- Renal Cell Carcinoma
- Neuroendocrine Tumors
- Imatinib Mesylate
- Cancer Genomics
- Hepatocellular Carcinoma
- Endoscopic Resection
- Cholangiocarcinoma
- Treatment
- Molecular Characterization
- Surgical Management
- Surgical Complications
- Immunotherapy
- Chemotherapy
- Pancreatic Cancer
- Prognostic Factors
- Clinical Practice Guidelines
- Survival Analysis
- Biliary Tract Cancer
- Genetic Mutations
- Gastric Cancer
- Liver Cancer
- Mutational Signatures
- Metastatic
- Pancreatic Neuroendocrine Tumors
- Sunitinib
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 25 words, with their numbers
- Chemotherapy522 topics
- Immunotherapy482 topics
- Pancreatic Cancer401 topic
- Surgical Complications401 topic
- Prognostic Factors323 topics
- Surgical Management242 topics
- Clinical Practice Guidelines222 topics
- Molecular Characterization202 topics
- Survival Analysis202 topics
- Treatment182 topics
- Biliary Tract Cancer161 topic
- Cholangiocarcinoma161 topic
- Genetic Mutations162 topics
- Endoscopic Resection121 topic
- Gastric Cancer121 topic
- Hepatocellular Carcinoma101 topic
- Liver Cancer101 topic
- Cancer Genomics91 topic
- Mutational Signatures91 topic
- Imatinib Mesylate81 topic
- Metastatic81 topic
- Neuroendocrine Tumors81 topic
- Pancreatic Neuroendocrine Tumors81 topic
- Renal Cell Carcinoma81 topic
- Sunitinib81 topic
Where does Shoichi Hishinuma work?
Shoichi Hishinuma's main affiliation in the publication record is Tochigi Cancer Center, Japan.
How many publications and citations does Shoichi Hishinuma have?
OpenAlex counts 83 works and 2,622 citations for Shoichi Hishinuma, an h-index of 19, ranking #4,549,924 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Shoichi Hishinuma. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.